Type your tag names separated by a space and hit enter

Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection

Evidence Summaries

Level of Evidence = B

Adjunctive corticosteroids appear to reduce mortality in HIV-infected patients with Pneumocystis jiroveci pneumonia.

A Cochrane review 1 included 7 small studies. Risk ratios for overall mortality for adjunctive corticosteroids were 0.56 (95% CI 0.32 to 0.98) at 1 month and 0.59 (95% CI 0.41 to 0.85) at 3–4 months of follow-up. To prevent 1 death, numbers needed to treat were 9 patients in a setting without highly active antiretroviral therapy (HAART) available, and 23 patients with HAART available. Only the 3 largest trials provided data on the need for mechanical ventilation with a risk ratio of 0.38 (95% CI 0.20 to 0.73) in favour of adjunctive corticosteroids. One study was conducted in infants, suggesting a risk ratio for death in hospital of 0.81 (95% CI 0.51 to 1.29).

Comment: The quality of evidence is downgraded by imprecise results (limited study size for each comparison).

References

1. Ewald H, Raatz H, Boscacci R et al. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev 2015;4():CD006150.  [PMID:25835432]


Copyright © 2017 Duodecim Medical Publications Limited.
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection is a sample topic from the Evidence-Based Medicine Guidelines.

To view other topics, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Learn more.

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection ID - 454227 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454227/all/Adjunctive_corticosteroids_for_Pneumocystis_jiroveci_pneumonia_in_patients_with_HIV_infection PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -